Help on the horizon for Polycythemia Vera with rusfertide (PTG-300) as a possible option to reduce erythrocytosis in some patients?
This sounds like something we need to keep our finger on. Looks like a huge breakthrough and we will be looking forward to the 2021 EHA Annual Congress and other publications. At this point, it seems like a good idea to ask your hematologist what this might mean for you!
Connect with us
We will keep you updated with more articles like this one
- Lisa Wiest
Blood cancer DX 1/5/17 (CLL). I am a nobody in the grand scheme. I can choose to be overwhelmed by my circumstances and all the "whys" and "what fors" or I can surrender. I choose surrender. By the grace of God through Jesus Christ, I have become a Child of God. Being on His team is the only sure thing in this life. This is my journey. A peek into my joys, fears, and passions. Come along with me and smell the flowers along the way. ~Lisa You can e-mail Lisa here.
- Market Research on Car T Therapy--a paid study for USA residents from Health Union June 14, 2023
- Paid Research Opportunity for UK residents on Social Isolation During the Covid-19 Pandemic April 2, 2023
- A New Survey From Our Partners at Health Union for USA Blood Cancer Patients March 23, 2023
- Remembering Tom Henry: Pharmacist, CLL Patient, Advocate, Spouse, Father, and Friend one year later February 9, 2023
- Watch and Wait, Watchful Waiting, W&W, and Watch and WORRY--what does it all mean? February 5, 2023